体外膜氧合支持下的连续性肾替代治疗  

Continuous renal replacement therapy with the support of extracorporeal membrane oxygenation

作　　者：周益平 缪惠洁 张育才 ZHOU Yi-ping;MIAO Hui-jie;ZHANG Yu-cai(Department of Critical Care Medicine,Shanghai Children's Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200040,China)

机构地区：[1]上海市儿童医院、上海交通大学医学院附属儿童医院重症医学科,上海200062

出　　处：《中国实用儿科杂志》2023年第2期109-113,共5页Chinese Journal of Practical Pediatrics

基　　金：上海市科委“科技创新行动计划”医学创新研究专项(20Y11901300);上海市科委自然科学基金项目(20ZR1446500)。

摘　　要：体外膜氧合(ECMO)用于挽救性治疗心肺衰竭患者,连续性肾替代治疗(CRRT)也越来越多地用于管理ECMO患者合并急性肾损伤(AKI)和(或)液体超载(FO)、电解质酸碱紊乱。CRRT与ECMO联合使用时需要考虑适应证、连接方式的选择、何时启动与终止CRRT、并发症、抗凝方式和药物浓度等技术性因素。Extracorporeal membrane oxygenation(ECMO)is used in salvage treatment for patients with cardiopulmonary failure.Continuous renal replacement therapy(CRRT)is increasingly used to manage the acute kidney injury(AKI)and/or fluid overload(FO),and electrolyte acid-base disorders in patients receiving ECMO support.Multiple factors need to be considered when CRRT is used in combination with ECMO,including the indications,connection mode,when to initiate and terminate CRRT,complications,anticoagulation,and drug concentration.

关 键 词：体外膜氧合 连续肾替代治疗 儿童 

分 类 号：R72[医药卫生—儿科]